1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Monoclonal Antibodies Revenue
1.4 Market Analysis by Type
1.4.1 Global Monoclonal Antibodies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cancer
1.4.3 Autoimmune Diseases
1.4.4 Infection
1.4.5 Hematological Diseases
1.4.6 Others
1.5 Market by Application
1.5.1 Global Monoclonal Antibodies Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Autoimmune and inflammatory diseases
1.5.4 Respiratory diseases
1.5.5 Ophthalmology
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Monoclonal Antibodies Market
1.8.1 Global Monoclonal Antibodies Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Monoclonal Antibodies Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Monoclonal Antibodies Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Monoclonal Antibodies Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Monoclonal Antibodies Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Monoclonal Antibodies Sales Volume Market Share by Region (2015-2020)
3.2 Global Monoclonal Antibodies Sales Revenue Market Share by Region (2015-2020)
3.3 North America Monoclonal Antibodies Sales Volume
3.3.1 North America Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.3.2 North America Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Monoclonal Antibodies Sales Volume
3.4.1 East Asia Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Monoclonal Antibodies Sales Volume (2015-2020)
3.5.1 Europe Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Monoclonal Antibodies Sales Volume (2015-2020)
3.6.1 South Asia Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Monoclonal Antibodies Sales Volume (2015-2020)
3.7.1 Southeast Asia Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Monoclonal Antibodies Sales Volume (2015-2020)
3.8.1 Middle East Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Monoclonal Antibodies Sales Volume (2015-2020)
3.9.1 Africa Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Monoclonal Antibodies Sales Volume (2015-2020)
3.10.1 Oceania Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Monoclonal Antibodies Sales Volume (2015-2020)
3.11.1 South America Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.11.2 South America Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Monoclonal Antibodies Sales Volume (2015-2020)
3.12.1 Rest of the World Monoclonal Antibodies Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Monoclonal Antibodies Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Monoclonal Antibodies Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Monoclonal Antibodies Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Monoclonal Antibodies Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Monoclonal Antibodies Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Monoclonal Antibodies Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Monoclonal Antibodies Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Monoclonal Antibodies Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Monoclonal Antibodies Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Monoclonal Antibodies Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Monoclonal Antibodies Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Monoclonal Antibodies Sales Volume Market Share by Type (2015-2020)
14.2 Global Monoclonal Antibodies Sales Revenue Market Share by Type (2015-2020)
14.3 Global Monoclonal Antibodies Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Monoclonal Antibodies Consumption Volume by Application (2015-2020)
15.2 Global Monoclonal Antibodies Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Monoclonal Antibodies Business
16.1 AbbVie
16.1.1 AbbVie Company Profile
16.1.2 AbbVie Monoclonal Antibodies Product Specification
16.1.3 AbbVie Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Formation Biologics
16.2.1 Formation Biologics Company Profile
16.2.2 Formation Biologics Monoclonal Antibodies Product Specification
16.2.3 Formation Biologics Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Amgen
16.3.1 Amgen Company Profile
16.3.2 Amgen Monoclonal Antibodies Product Specification
16.3.3 Amgen Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Roche
16.4.1 Roche Company Profile
16.4.2 Roche Monoclonal Antibodies Product Specification
16.4.3 Roche Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Eli Lilly
16.5.1 Eli Lilly Company Profile
16.5.2 Eli Lilly Monoclonal Antibodies Product Specification
16.5.3 Eli Lilly Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Johnson & Johnson
16.6.1 Johnson & Johnson Company Profile
16.6.2 Johnson & Johnson Monoclonal Antibodies Product Specification
16.6.3 Johnson & Johnson Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 GlaxoSmithKline
16.7.1 GlaxoSmithKline Company Profile
16.7.2 GlaxoSmithKline Monoclonal Antibodies Product Specification
16.7.3 GlaxoSmithKline Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 BMS
16.8.1 BMS Company Profile
16.8.2 BMS Monoclonal Antibodies Product Specification
16.8.3 BMS Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Merck
16.9.1 Merck Company Profile
16.9.2 Merck Monoclonal Antibodies Product Specification
16.9.3 Merck Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Genmab
16.10.1 Genmab Company Profile
16.10.2 Genmab Monoclonal Antibodies Product Specification
16.10.3 Genmab Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Pfizer
16.11.1 Pfizer Company Profile
16.11.2 Pfizer Monoclonal Antibodies Product Specification
16.11.3 Pfizer Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Synthon Biopharmaceuticals
16.12.1 Synthon Biopharmaceuticals Company Profile
16.12.2 Synthon Biopharmaceuticals Monoclonal Antibodies Product Specification
16.12.3 Synthon Biopharmaceuticals Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Human Genome Sciences
16.13.1 Human Genome Sciences Company Profile
16.13.2 Human Genome Sciences Monoclonal Antibodies Product Specification
16.13.3 Human Genome Sciences Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Teva
16.14.1 Teva Company Profile
16.14.2 Teva Monoclonal Antibodies Product Specification
16.14.3 Teva Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Seattle Genetics
16.15.1 Seattle Genetics Company Profile
16.15.2 Seattle Genetics Monoclonal Antibodies Product Specification
16.15.3 Seattle Genetics Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Novartis
16.16.1 Novartis Company Profile
16.16.2 Novartis Monoclonal Antibodies Product Specification
16.16.3 Novartis Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 mmunogen
16.17.1 mmunogen Company Profile
16.17.2 mmunogen Monoclonal Antibodies Product Specification
16.17.3 mmunogen Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Takeda
16.18.1 Takeda Company Profile
16.18.2 Takeda Monoclonal Antibodies Product Specification
16.18.3 Takeda Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Stemcentrx
16.19.1 Stemcentrx Company Profile
16.19.2 Stemcentrx Monoclonal Antibodies Product Specification
16.19.3 Stemcentrx Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.20 MedImmune
16.20.1 MedImmune Company Profile
16.20.2 MedImmune Monoclonal Antibodies Product Specification
16.20.3 MedImmune Monoclonal Antibodies Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Monoclonal Antibodies Manufacturing Cost Analysis
17.1 Monoclonal Antibodies Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Monoclonal Antibodies
17.4 Monoclonal Antibodies Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Monoclonal Antibodies Distributors List
18.3 Monoclonal Antibodies Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Monoclonal Antibodies (2021-2026)
20.2 Global Forecasted Revenue of Monoclonal Antibodies (2021-2026)
20.3 Global Forecasted Price of Monoclonal Antibodies (2015-2026)
20.4 Global Forecasted Production of Monoclonal Antibodies by Region (2021-2026)
20.4.1 North America Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.4.3 Europe Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.4.7 Africa Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.4.9 South America Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Monoclonal Antibodies Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Monoclonal Antibodies by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Monoclonal Antibodies by Country
21.2 East Asia Market Forecasted Consumption of Monoclonal Antibodies by Country
21.3 Europe Market Forecasted Consumption of Monoclonal Antibodies by Countriy
21.4 South Asia Forecasted Consumption of Monoclonal Antibodies by Country
21.5 Southeast Asia Forecasted Consumption of Monoclonal Antibodies by Country
21.6 Middle East Forecasted Consumption of Monoclonal Antibodies by Country
21.7 Africa Forecasted Consumption of Monoclonal Antibodies by Country
21.8 Oceania Forecasted Consumption of Monoclonal Antibodies by Country
21.9 South America Forecasted Consumption of Monoclonal Antibodies by Country
21.10 Rest of the world Forecasted Consumption of Monoclonal Antibodies by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer